Protective efficacy of a SARS-CoV-2 DNA Vaccine in wild-type and immunosuppressed Syrian hamsters
R. Brocato, S. A. Kwilas, R. K. Kim, X. Zeng, L. M. Principe, J. M. Smith, J. Hooper
This study evaluates a SARS-CoV-2 DNA vaccine in Syrian hamsters, showing it is protective in both healthy and immunosuppressed models.
bioRxiv · Nov 10, 2020Microbiology